Constipation in childhood what is new for pediatricians and dietitians?
|
|
- Charleen Hood
- 5 years ago
- Views:
Transcription
1 Constipation in childhood what is new for pediatricians and dietitians? Jan Taminiau-Marc Benninga Emma Children s Hospital / AMC, Amsterdam / The Netherlands
2 Approach of the child Complaints History Findings Laboratory Therapeutic options Follow up
3 What to ask a patient History: Is it possibly constipation? Number of defecations per week Episodes of fecal incontinence per week Retentive posturing or excessive volitional stool retention History of painful or hard bowel movements History of large diameter stools which may obstruct the toilet Presence of a large fecal mass in the rectum
4 History Meconium production within 48 hours after birth Obstruction: Vomiting, bilious Pain after eating Poor appetite Malnutrition, weight loss Distended abdomen, ileus, bowel sounds Hirschsprung, explosive defecation, red face, once every week
5 Solitary rectal ulcer Usually adolescents takes 1-2 years on laxatives to cure
6 Laboratory investigations On indication not as screening Hypochromic anemia correlation to intake Hypothyroidism Hypercalcemia Salt loosing nephropathy, dehydration Celiac IgA TTG Stool cultures, calprotectin, elastase Mantoux Disaccharidases in duodenal biopsy
7 Investigations Flat X ray abdomen dilated loops Large bowel-small bowel Transit time, small and large bowel Lactulose breath test, small bowel transit Abdominal ultrasound Sigmoidoscopy Rectal biopsy Ano-rectal manometry to show a rectal inhibitory reflex with distension (small balloon insufflation)
8 Constipation Transit time normal 60% of constipated children Treatment trial and error
9 Transit time Initial X-Ray After swallowed rings X-Ray
10 Diagnosis Slow transit constipation With laxatives
11 Cochrane review correlation of investigations to clinical symptoms of constipation Abdominal radiography Colonic transit time (CTT) Rectal ultrasound scanning (US) for rectal diameter No correlation of clinical symptoms of constipation to fecal loading on Abdominal radiography, CTT or Rectal US Berger J Ped 2012
12 Rome IV diagnostic Criteria for Functional Constipation Children older than 4 years Must include 2 or more of the following occurring at least once per week for a minimum of 1 month with insufficient criteria for a diagnosis of irritable bowel syndrome: 2 or fewer defecations in the toilet per week At least 1 episode of fecal incontinence per week History of retentive posturing or excessive volitional stool retention History of painful or hard bowel movements Presence of a large fecal mass in the rectum History of large diameter stools that can obstruct the toilet
13 Rome IV Diagnostic Criteria for Functional Constipation Infants and toddlers up to the age of 4 Must include 1 month of at least 2 of the following: 2 or fewer defecations per week History of excessive stool retention History of painful or hard bowel movements History of large-diameter stools Presence of a large fecal mass in the rectum In toilet-trained children, the following additional criteria may be used: At least 1 episode/week of incontinence after the acquisition of toileting skills
14 Rome IV Diagnostic Criteria for Infant Dyschezia Must include in an infant <9 months of age: 1. At least 10 minutes of straining and crying before successful or unsuccessful passage of soft stools 2. No other health problems Infant with defecation discomfort: Uncomfortable defecation in infants is not identical to constipation Therapy: Dietary measures, cow s milk issue, soluble fiber
15 Rome IV diagnostic Criteria for Non-retentive Fecal Incontinence At least a 1-month history of the following symptoms in a child with a developmental age older than 4 years: 1. Defecation into places inappropriate to the sociocultural context 2. No evidence of fecal retention 3. After appropriate medical evaluation, the fecal incontinence cannot be explained by another medical condition
16 Treatment of children with functional non-retentive faecal incontinence (soiling) Explanation and support for the child and parents Non - accusatory approach Toilet training program with a rewarding system Biofeedback training no or only a minor role If necessary referral to a mental health professional is recommended
17 Average prevalence for children is 12 % 0-10% >10-20% >20-30% >30-40% Mugie SM, et al. Best Pract & Res Clin Gastroenterol 2011
18 0-10% Calabar Prevalence in schools >10-20% >20-30% >30-40% Mugie SM, et al. Best Pract & Res Clin Gastroenterol 2011
19 Age specific prevalence of functional constipation among adolescent Nigerians
20 Prevalence of constipation according to gender in Nigeria
21 CFC represents a significant burden on the health care system... Reported in two years in USA 1,7 (1.1%) million constipated children More outpatient visits and Emergency Dep visits More days of school missed Children with constipation: $3,374/year Children without: $1,096/year Total extra burden of childhood constipation 4 billion dollar/year in the US Liem O, et al. J Pediatr 2009
22 What keeps children constipated?
23 Behavior Mechanisms of Constipation Abuse Nerves, muscles, ICCs + Stress Food Genetics Sensation
24 Fibers Cow s milk Probiotics
25 Prevalence of constipation in pre-school children Underconsumption of plant foods? 368 children, 3-5 yrs (kindergarten) 28,8% constipation (Rome II criteria)! Median dietary fiber intake of constipated children was significantly lower than non-constipated children: 3.4 g/d vs. 3.8 g/d, p = (weight ± 17 kg) Corresponding to 40% reference dietary fiber intake No difference in fluid intake Lee WT et al. J Pediatr Child Health 2007
26 Wheat Bran and Stool Weight: A Dose / Response Increase in stool weight over baseline (g) p<0.01 n Wheat fiber (g) Stephen et al. Br J Nutr. 1986
27 Effect of Glucomannan 2.5 gr/d in the treatment of childhood constipation Median number / week p = NS * * n= yr Baseline 4 weeks later 0 Defecation Gluc Defecation Placebo Chmielewska A, et al. Clin Nutr 2011
28 Success % Glucomannan vs placebo Rate of success 80 P=NS % 58% Gluco Placebo 95% CI 38%-72% 95% CI 41%-74% Chmielewska A, et al. Clin Nutr 2011
29 AFPFF 18 gr vs PEG E 0.5 gr/kg as treatment for childhood constipation AFPFF PEG 3350 NS Improvement Rate Def freq/w from N = ± 2.7 yrs Enrolment 2 weeks 4 weeks 8 weeks AFPFF (Acacia fiberpsyllium fiber-fructose) Quitadamo P, et al. J Pediatr 2012
30 RCT: plums(prunes) vs. psyllium(6gram) for Constipation in adults The laxative effects of plums a combination: sorbitol (14.7g 100g) dietary fiber (6g 100g) polyphenols (184 mg 100g) exact mechanism has not been established plums softer stools less staining Attalauri et al. Aliment Pharmacol Ther 2011
31 Effectiveness of using a behavioral intervention to improve dietary fiber intake in children with constipation No significant benefit was demonstrated in terms of a reduction in laxative use or increased stool frequency associated with additional fiber intake!!!!! CG 10 grams IG 14 grams Sullivan PB, et al. J Hum Nutr Diet, 2011
32 Have to eat 30 grams of fiber 1.5 kilogram of fruits daily
33
34 IBS children Healthy children Haemophilus parainfluenzae Ruminococcus Alistipes Prominent in IBS Saulnier DM, et al. Gastroenterology 2011
35 Constipation Rationale for the use of probiotics Differences in the intestinal microbiota in healthy and constipated subjects bifidobacteria non-pathogenic E coli, bacteroides total number of microorganisms Improved transit time Several studies involving B. animalis DN Zoppi G, et al. Acta Paediatr 1998 Salminen S, et al. Scand J Gastro 1997 Picard C, et et al. Aliment Pharmacol Ther 2005
36 Functional constipation in children Bifidum bacterium lactis DN Functional constipation (Rome III criteria) Aged 3 to 16 y N=159 N=79 B lactis DN x10 10 CFU Orally BID, for 3 weeks N=80 Placebo Orally, for 3 weeks N=74 ITT analysis N=74 ITT analysis Tabbers MM et al. Pediatrics 2011
37 Primary outcome The change in stool frequency from baseline to after 3 wk of product consumption Probiotic group n = 74 Control group n = 74 MD 0.3 (95% CI to 0.51) P=0.35 Tabbers MM et al. Pediatrics 2011
38 Secondary outcome Success rate 3 BM per wk and <1 fecal incontinence episodes in 2 wk 40% 30% 38% 24% Probiotic group n = 74 20% 10% Control group n = 74 0 RR 1.6 (95% CI 0.97 to 2.7) P=0.06 Tabbers MM et al. Pediatrics 2011
39 Functional constipation in children B lactis DN In constipated children, the fermented dairy product containing B lactis DN did increase stool frequency, but this increase was comparable in the control group Insufficient evidence to recommend fermented dairy products containing B lactis strain DN in this category of patients Tabbers et al. Pediatrics 2011.
40 Probiotics for functional constipation RCTs in children - summary Reference Probiotic Constipation N Effect Banaszkiewicz & Szajewska 2005 Bu et al Coccorullo et al LGG L casei rhamnosus Lcr35 <3 BM per wk for at least 12 wk <3 BM per wk for >2 mo 60 NS 27 (?) L reuteri DSM Rome III criteria 44 Tabbers et al B lactis DN Rome III criteria 160 NS Guerra et al B longum Rome III criteria 59 Total 350
41
42 A vicious circle of learned behavior Large hard stools stools Large / hard Pain Pain Stool Stoolwithholding behavior withholding behavior Van Dijk M, et al. Pediatrics 2009
43 Biofeedback training in the treatment of childhood constipation: a RCT 80 NS % 32% 52% 47% 59% 50% 57% 48% weeks 6 months 1 year 1.5 year CT (N = 94) CT + BF (n = 98) Van der Plas RN, et al. Lancet 1996
44 Behavioral therapy for childhood constipation: a randomized, controlled trial Defecation frequency per week Baseline Posttreatment Follow-up CT BT * *p=.025 Fecal incontinence frequency per week Baseline Posttreatment Follow-up CT BT NS Success (%) Posttreatment Follow-up CT BT NS
45
46 Behavioral therapy for childhood constipation: a randomized, controlled trial Behavioral therapy with laxatives has no advantage over CT in treating childhood constipation Behavioral therapy was focused on removing fear for defecation, aggressive behavior more related However, when behavior problems are present, behavioral therapy or referral to mental health services should be considered, might shorten treatment period Van Dijk M, et al. Pediatrics 2008
47 Pediatric constipation: current treatment strategies New drugs Pelvic floor surgery Colectomy or Stoma (inc. anterograde irrigation) % patients Diagnosis (exclusion of organic pathology) Lifestyle modifications Diet, fluid, exercise Oral and / or rectal laxatives Nurse-led Bowel retraining +/- biofeedback Transabdominal electrical stimulation Sacral nerve stimulation time
48
49 4 STEPS Education / demystification / toilet training Disimpaction Maintenance Follow-up NASPGHAN guidelines, JPGN, 2006
50
51 Baseline characteristics Enema PEG p-value Number Male Age in years 7.9± ±2.6 Defecation/wk 1.9± ± Symptom duration (years) 5.2± ± Daytime fecal incontinence/wk 15.7± ± Night time fecal incontinence 28% 34% 0.70 Abdominal pain 48% 64% 0.37 Watery stools 4% 9% 0.18 Bekkali et al, J Pediatr 2009
52 Results 6 days daily enemas or 6 days 1.5 gr PEG daily Enemas n=46 PEG n=44 Drop-outs n=5 Successful disimpaction n=37 80% Successful disimpaction n=30 68% Drop-outs n=5 *chi 2 statistics p=0.28 (ITT) Bekkali et al, J Pediatr 2009
53 Defecation Defecation frequency/ wk (±SE) ns Intake * ns Disimpaction Enema PEG
54 Fecal incontinence / wk Fecal incontinence * ns * Enema PEG Intake Disimpaction
55 Adverse events % 70 ns Enema PEG Abdominal pain
56 Adverse events % ns Enema PEG Anxiety
57 One Enema followed by oral Clean out versus oral clean out Miller KM, et al. Ped Emer Care 2012
58 Enema versus oral Clean out P = % vs 28%; no stools since ED discharge in the enema arm Miller KM, et al. Ped Emer Care 2012
59 Enema versus oral Clean out 54% of children in the enema arm were reported as somewhat upset or very upset by the therapy No children in the oral cleanout arm were upset (P < 0.05) The majority of all families (95%) reported their ED visit was very helpful. Miller KM, et al. Ped Emer Care 2012
60
61 2011
62 Stool Frequency per Week Cochrane Database Syst Rev 2011
63 Lactulose versus PEG Polyethylene glycol is better than lactulose in outcomes of: Stool frequency per week Form of stool Relief of abdominal pain Need for additional medication Polyethylene Glycol should be used in preference to Lactulose in the treatment of Chronic Constipation Cochrane Database Syst Rev 2011
64 Percentage Long term Follow-up and constipation No succes lax+ No succes lax- Succes lax+ Succes lax- 0 0, Time of follow-up (years) Bongers et al. Pediatrics 2010
65 One year treatment of childhood constipation PEG 3350 with electrolytes vs PEG 4000 A double blind RCT N = 97 (age 6 16 years) Children defecation freq < 3/wk + at least one other Rome III criterion 12 month-treatment Bekkali N et al DDW 2012;A1398
66 Percentage One year treatment of childhood constipation PEG 3350 with electrolytes vs PEG 4000 A double blind RCT NS Success percentage at 12 months PEG 3350 PEG 4000 Bekkali N et al DDW 2012;A1398
67
68 Percentage Enemas versus oral laxatives for one year in children with chronic constipation: RCT 80 NS E CT Months Bongers M et al. Clin Gastroenterol Hepatol. 2009
69
70 Long-term effects of transabdominal electrical stimulation in treating children with slow-transit constipation 39 patients with STC (12-18 yrs) 9-V battery-operated interferential stimulating machine 2 electrodes on the anterior adominal wall and 2 electrodes placed on the back between T9 and L2 on either side Physiotherapists administered 1 to 2 months of TES to 39 children (20 minutes, 3 times a week) 15 continued to self-administer TES (30 minutes daily for more than 2 months) Ismail et al. J Pediatr Surg 2009 Leong et al. J Pediatr Surg 2011
71 Long-term effects of transabdominal electrical stimulation in treating children with slow-transit constipation Leong et al. J Pediatr Surg 2011
72 Long-term effects of transabdominal electrical stimulation in treating children with slow-transit constipation 73% of patients perceived improvement, lasting more than 2 years in 33% and less than 6 months in 25% to 33% Perception of urge initiated defecations improved 80% from nil Leong et al. J Pediatr Surg 2011
73 Sacral nerve stimulation Introduced as therapy in urology Indications: overactive bladder symptoms urgency incontinence urinary retention fecal incontinence pelvic floor dysfunction constipation
74 Sacral Neuromodulation Therapy: A Promising Treatment for Adolescents With Refractory Functional Constipation Patients fulfilled Rome III criteria for functional constipation Not responding to intensive conservative treatment (oral and/or rectal laxatives, or colonic lavage, and behavioral approaches) No urge to defecate, no spontaneous defecation 30 girls, median age of 15.2 years (range, 10 18) Median therapy duration at time of inclusion was 7 years (range, 1 17 years)
75 Sacral Neuromodulation Therapy: A Promising Treatment for Adolescents With Refractory Functional Constipation A tined lead is inserted through needle Needle removed 1 4 weeks testing period with external device Permanent neuromodulator Van Wunnik et al Dis Colon Rect 2012
76 Defecation frequency per week Follow-up (months)
77 Abdominal pain Follow-up (months
78 Sacral Neuromodulation Therapy: Conclusion SNM seems to be an effective short-term treatment in adolescents with chronic functional constipation refractory to intensive conservative treatment Improvement of defecation frequency, urge to defecate and reduction of severe abdominal pain Sustained effects up to 2 years However longer term follow up is warranted Van Wunnik et al Dis Colon Rect 2012
79 120 sensor fiber optic catheter
80 Mid ascending colon Colonic respons to sacral nerve stimulation in constipation SNS Splenic flexure sigmoid colon 60min Dinning et al. Br J Surg 2012
81 NEW DRUGS in the pipeline
82 New and emerging drugs for constipation Ileal bile acid A3309 Stimulates propulsive motility Phase IIb transporter inhibitor and fluid secretion
83 Efficacy in chronic constipation: 3 SCBM/week % subjects with an average of 3 SCBM per week over 12 weeks (normalisation) 35% 30% 28.9*** 28.9*** 25% 23.6*** 24.7*** 23.6*** 23.9** 23.5** 20% 19.5** 15% 10% % 0% n=236 n=214 n=190 Pooled data INT -6 USA -13 USA -11 Placebo PRU 2 mg PRU 4 mg **p<0.01 vs. placebo ***p<0.001 vs. placebo Camilleri et al. N Engl J Med 2008 Tack et al. Gut 2009 E Quigley et al. Aliment Pharmacol Ther 2009
84 Prucalopride in children with constipation 37 subjects (24M/13F) ages 4 to 12 years enrolled In case of impaction, a clean-out was completed before entry 0.01 to 0.03 mg/kg/day PRU oral solution Treatment for 8 weeks Evaluation of Efficacy, Safety and Tolerability Winter H. et al. DDW 2009;A
85 Prucalopride in children with constipation PRU at doses of 0.01 to 0.03 mg/kg/day for 8 weeks in children aged 4 to 12 years with functional constipation appears to be Safe Efficacious Children who were passing < 3 BM/week had a rapid response to PRU and passed an average of 1 BM/day within one week of starting therapy Well tolerated Most frequently reported AEs: headache (24%), abdominal pain (22%), upper respiratory tract infection (19%) Most AEs were:mild and moderate in severity often associated with the highest dose of PRU Winter H. et al. DDW 2009;A
86 Common osmotic laxatives in children Laxative Dosage Side Effects Lactulose 1-3 ml/kg 1 or 2 times daily Flatulence, abdominal pain Lactitol 5-40 gr 1 or 2 times daily Flatulence, abdominal pain Magnesium oxide mgr/day Hypermagnesaemia due to concurrent renal failure Milk of magnesia >6 months: 1-3 ml/kg/day (divide into 1-2 doses) See previous PEG maintenance gr/kg/day Loose stools, bad taste (PEG+additional electrolytes) PEG 3350 disimpaction gr/kg/day See previous Mineral oil (liquid paraffin) >12 months: 1-3 ml/kg/day Bad taste, anal leakage, aspiration pneumonia < 12 months
87 Stimulant laxatives Stimulant laxatives Bisacodyl Senna Sodium picosulfate Dosages 3-10 y: 5 mg /day > 10 y: 5-10 mg /day 2-6 y: mg once or twice/day 6-12 y: mg /day > 12 y: mg /day 1 month-4 y: mg once/day 4-18 y: mg once/day
88 Enemas Rectal laxatives/enemas Bisacodyl Sodium docusate Sodium phosphate Dosages 2-10 y: 5 mg once /day > 10 y: 5-10 mg once /day < 6 y: 60 ml > 6 y: 120 ml 1-18 y: 2.5 ml/kg, max. 133 ml/dose NaCl Mineral oil neonate < 1 kg: 5ml, > 1kg: 10 ml > 1 y: 6 ml/kg once or twice/day 2-11 y: ml once/day > 11 y: ml once/day
89 Percentage Long term Follow-up and constipation No succes lax+ No succes lax- Succes lax+ Succes lax- 0 0, Time of follow-up (years) Bongers et al. Pediatrics 2010
90 Conclusions The role of fibre remains uncertain The role of the microbiome should be explored Probiotics are not recommended Stool withholding behaviour important in young children PEG is the first choice as maintenance Enemas have no role as maintenance treatment TES and SNS are promising New drugs such as prucalopride, linaclotide and lubiprostone are promising in adults but should be tested in children with constipation
91 Thank you
Childhood constipation, a real problem..? Marc Benninga, Emma Children s Hospital, AMC, Amsterdam, the Netherlands
Childhood constipation, a real problem..? Marc Benninga, Emma Children s Hospital, AMC, Amsterdam, the Netherlands Constipation 0-10% >10-20% >20-30% >30-40% Mugie SM, et al. Best Pract & Res Clin Gastroenterol
More informationTREATMENT SOCIETY GUIDELINES FOR CONSTIPATION: WHAT IS NEW? FUNCTIONAL CONSTIPATION
SOCIETY GUIDELINES FOR CONSTIPATION: WHAT IS NEW? Samuel Nurko MD MPH Center for Motility and Functional Gastrointestinal Disorders FUNCTIONAL CONSTIPATION One of the most common functional GI disorders
More informationTreatment of functional constipation in children: Evidence-based recommendations from ESPGHAN and NASPGHAN 2014
Treatment of functional constipation in children: Evidence-based recommendations from ESPGHAN and NASPGHAN 2014 BS. Nguyễn Thị Kim Ngân Khoa Tiêu Hóa BV Nhi Đồng 2 Introduction Constipation is a common
More informationElderly Man With Chronic Constipation
Elderly Man With Chronic Constipation Linda Nguyen, MD Director, Neurogastroenterology and Motility Clinical Assistant Professor Stanford University Overview Normal bowel function Defining Constipation:
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationCONSTIPATION. Atan Baas Sinuhaji
CONSTIPATION Atan Baas Sinuhaji Sub Division of Pediatrics Gastroentero-Hepatolgy Department of ChildHealth,School of Medicine University of Sumatera Utara MEDAN DEFECATION REGULAR PATTERN CONSTIPATION
More informationESPEN Congress The Hague 2017
ESPEN Congress The Hague 2017 Specific nutritional care in children The role of food in children with functional gastrointestinal disorders M. Benninga (NL) The role of food in children with functional
More informationEvidence-based Treatment Strategies for
Evidence-based Treatment Strategies for Chronic Constipation William D. Chey, MD Professor of Medicine University of Michigan Rome III criteria*: Chronic constipation Must include 2 of the following (>25%
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Constipation: management of idiopathic constipation in children in primary and secondary care 1.1 Short title Constipation
More informationEfficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club
Efficacy and Safety of Lubiprostone Laura Wozniak February 23, 2010 K30 Monthly Journal Club Objectives Brief overview of constipation Review of article Discussion Constipation in Children 3-5% of all
More informationConstipation an Old Friend. Presented by Dr. Keith Harris
Constipation an Old Friend Presented by Dr. Keith Harris Irregularity and the Tricks of the Trade." CONSTIPATION What is constipation? INFREQUENT BOWEL MOVEMENTS DIFFICULTY DURING DEFECATION SENSATION
More informationPaediatric constipation
EARN 3 FREE CPD POINTS constipation Leader in digital CPD for Southern African healthcare professionals Best practice Paediatric constipation Diagnosis and treatment Dr Tim De Maayer Paediatric Gastroenterologist
More informationPaediatric constipation and functional non-retentive faecal soiling Voskuijl, W.P.
UvA-DARE (Digital Academic Repository) Paediatric constipation and functional non-retentive faecal soiling Voskuijl, W.P. Link to publication Citation for published version (APA): Voskuijl, W. P. (2005).
More informationPrescribing Guidance for the Treatment of Constipation in Children
Prescribing Guidance for the Treatment of Constipation in Children Effective Date: July 2007 Reviewed: September 2009 & December 2011 Review Date: December 2013 Gateshead Medicines Management Approved
More informationConstipation in children
Search date August 2003 Gregory Rubin QUESTIONS Effects of treatments...397 395 INTERVENTIONS CONSTIPATION Trade off between benefits and harms Cisapride with or without magnesium oxide*...397 Unknown
More informationManagement of Neurogenic Bowel Dysfunction. Fiona Paul, DNP, RN, CPNP Center for Motility and Functional Gastrointestinal Disorders
Management of Neurogenic Bowel Dysfunction Fiona Paul, DNP, RN, CPNP Center for Motility and Functional Gastrointestinal Disorders DEFECATION Delivery of colon contents to the rectum Rectal compliance
More informationChronic constipation in the elderly
Chronic constipation in the elderly 1 Dec,2011 R 2 Natta Asanaleykha Epidemiology Definition Scope The impact of chronic constipation in the elderly Pathophysiology Evaluation the elderly patient with
More informationConstipation in Children. Amani Al Hajeri, MD, CABFM, IBFM, MSc MG*
1 Bahrain Medical Bulletin, Vol. 33, No. 4, December 2011 Education-Family Physician Corner Constipation in Children Amani Al Hajeri, MD, CABFM, IBFM, MSc MG* Constipation in pediatrics age group is frequently
More informationConstipation in childhood is characterized by a low defecation frequency in combination with either involuntary loss of
USE OF ROME II CRITERIA IN CHILDHOOD DEFECATION DISORDERS: APPLICABILITY IN CLINICAL AND RESEARCH PRACTICE WIEGER P. VOSKUIJL, MD, JAROM HEIJMANS, HUGO S. A. HEIJMANS, MD, PHD, JAN A. J. M. TAMINIAU,MD,PHD,
More informationIPS Childhood Constipation when we refer to Ped.Gastroenterologist? Dr.Muath Al Turaiki. Consultant of Pediatric Gastroenterology, K.S.
Childhood Constipation when we refer to Ped.Gastroenterologist? Dr.Muath Al Turaiki Consultant of Pediatric Gastroenterology, K.S.H Dubai 22-24 Feb. 2018 Objectives: Why constipation?!!! Is it a burden
More informationIrritable Bowel Syndrome. Mustafa Giaffer March 2017
Irritable Bowel Syndrome Mustafa Giaffer March 2017 Introduction First described in 1771. 50% of patients present
More informationComparing the efficacy of polyethylene glycol. glycol (PEG), magnesium hydroxide, lactulose. treatment of functional constipation in children
Original article Comparing the efficacy of polyethylene glycol (PEG), magnesium hydroxide and lactulosein treatment of functional constipation in children Hossein Saneian 1, Neda Mostofizadeh 2 1 Assistant
More informationHuman Anatomy rectum
rectum The colon is also called the large intestine. The ileum (last part of the small intestine) connects to the cecum (first part of the colon) in the lower right abdomen. The rest of the colon is divided
More informationOCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA
OMED 17 OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA 29.5 Category 1-A CME credits anticipated ACOFP / AOA s 122 nd Annual Osteopathic Medical Conference & Exposition Joint Session with ACOFP and Cleveland
More informationConstipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment
CONSTIPATION Constipation An Overview Definition Physiology of GI tract Etiology Assessment Treatment Definition Constipation = the infrequent passage of hard feces Definition of Infrequent The meaning
More informationActive ingredients per ml: Docusate sodium 1 mg/sorbitol solution (70%) (crystallising) 357 mg Structural formula: Docusate.
NAME OF THE MEDICINE KLYX Enema Active ingredients per ml: Docusate sodium 1 mg/sorbitol solution (70%) (crystallising) 357 mg Structural formula: Docusate Sorbitol C20H37NaO7S MW: 444.56 CAS no: 577-11-7
More informationBRIEF INTERVENTIONS: ENCOPRESIS
BRIEF INTERVENTIONS: ENCOPRESIS BI-PED PROJECT (BRIEF INTERVENTIONS: PEDIATRICS) Emotional Health Committee Maryland Chapter American Academy of Pediatrics David Bromberg M.D. Overview: Encopresis is diagnosed
More information15. Prevention of UTI and lifestyle modifications
15. Prevention of UTI and lifestyle modifications Key questions: Does improving poor voiding habits help prevent UTI recurrence? Does improving constipation help prevent UTI recurrence? Does increasing
More informationPrimary Care Constipation Guidelines. Version 1 November 2016
Primary Care Constipation Guidelines Version 1 November 2016 VERSION CONTROL Version Date Amendments made Version 1 November 2016 New guideline Contents 1. Management of constipation in adults: acute and
More informationSACRAL NERVE STIMULATION FOR EXPERIENCE IN CHILDREN
SACRAL NERVE STIMULATION FOR COLORECTAL DISEASES: EXPERIENCE IN CHILDREN C. LOUIS-BORRIONE - JM. GUYS TIMONE-ENFANTS MARSEILLE SACRAL NEUROMODULATION IN CHILDREN 26 : Humphreys et al - 23 children with
More informationEmerging Treatments for IBS-C and Clinical Trial Endpoints
Emerging Treatments for IBS-C and Clinical Trial Endpoints Lin Chang, M.D. Oppenheimer Family Center for Neurobiology of Stress David Geffen School of Medicine at UCLA Learning Objectives Describe current
More informationThe involuntary loss of feces in the underwear after. Longitudinal Follow-up of Children With Functional Nonretentive Fecal Incontinence.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 26;4:67 72 Longitudinal Follow-up of Children With Functional Nonretentive Fecal Incontinence WIEGER P. VOSKUIJL,* JOHANNES B. REITSMA, RIJK VAN GINKEL,* HANS A.
More informationUnderstanding & Alleviating Constipation. Living (Well!) with Gastroparesis Program Warm-Up Class
Understanding & Alleviating Constipation Living (Well!) with Gastroparesis Program Warm-Up Class Please Remember The information presented is for educational purposes only and is in no way intended as
More informationNational Institute for Health and Care Excellence. Surveillance programme
National Institute for Health and Care Excellence Surveillance programme Surveillance proposal consultation document Constipation in children and young people: diagnosis and management. NICE guideline
More informationGI Physiology - Investigating and treating patients with pelvic floor dysfunction. Lynne Smith Department of GI Physiology NGH Sheffield
GI Physiology - Investigating and treating patients with pelvic floor dysfunction Lynne Smith Department of GI Physiology NGH Sheffield Aims o o o To give an overview of lower GI investigations To demonstrate
More informationORIGINAL PAPER ABSTRACT INTRODUCTION
ORIGINAL PAPER Available from: URL: http://www.jgld.ro/2014/4/9 DOI: http://dx.doi.org/10.15403/jgld.2014.1121.234.elr The Effect of Lactobacillus reuteri Supplementation in Adults with Chronic Functional
More informationMOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l
MOVICOL -Half Powder for Solution (macrogol 3350) Product Name: Product Description: MOVICOL-Half Each sachet of MOVICOL-Half contains: Macrogol 3350 6.563 g Sodium chloride 175.4 mg Sodium bicarbonate
More informationConstipation Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.uk
THE DIGESTIVE SYSTEM http://healthfavo.com/digestive-system-for-kids.html This factsheet is about Constipation Constipation is a symptom that can mean different things to different people but the usual
More informationWhat Is Constipation?
CONSTIPATION What Is Constipation? Constipation is when you have infrequent or hard-to-pass bowel movements (meaning they are painful or you have to strain), have hard stools or feel like your bowel movements
More informationAuthors and Disclosures
Role of Carbon Dioxide-Releasing Suppositories in the Treatment of Chronic Functional Constipation A Double-Blind, Randomised, Placebo-Controlled Trial M. Lazzaroni; V. Casini; G. Bianchi Porro Authors
More informationConstipation is a common disorder in children,
The Effect of Anorectal Manometry on the Outcome of Treatment in Severe Childhood Constipation: A Randomized, Controlled Trial Rijk van Ginkel, MD*; Hans A. Büller, PhD ; Guy E. Boeckxstaens, PhD ; Roos
More informationBiofeedback for Pelvic Floor Disorders and Incontinence
The UNC Center for Functional GI & Motility Disorders www.med.unc.edu/ibs Biofeedback for Pelvic Floor Disorders and Incontinence Olafur S. Palsson, Psy.D. Associate Professor of Medicine UNC Center for
More informationChapter 19. Assisting With Bowel Elimination. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved.
Chapter 19 Assisting With Bowel Elimination Normal Bowel Elimination Time and frequency of bowel movements (BMs) vary. To assist with bowel elimination, you need to know these terms: Defecation is the
More informationEfficacy of a mixture of probiotic agents as complementary therapy for chronic functional constipation in childhood
Russo et al. Italian Journal of Pediatrics (2017) 43:24 DOI 10.1186/s13052-017-0334-3 RESEARCH Open Access Efficacy of a mixture of probiotic agents as complementary therapy for chronic functional constipation
More informationTITLE: Treatments for Constipation: A Review of Systematic Reviews
TITLE: Treatments for Constipation: A Review of Systematic Reviews DATE: 17 November 2014 CONTEXT AND POLICY ISSUES Constipation has many definitions and is often described differently depending on the
More informationAntidiarrheals Antidiarrheal
Antidiarrheals Major factors in diarrhea Increased motility of the GI tract. Decreased absorption of fluid. Antidiarrheal drugs include: Antimotility agents. Adsorbents. Drugs that modify fluid and electrolyte
More informationMANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES
Enrique Rey Professor of Medicine Head. Department of Digestive Diseases Hospital Clínico San Carlos Complutense University Madrid, Spain MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES CONSTIPATION:
More informationConstipation. What is constipation? What is the criteria for having constipation? What are the different types of constipation?
What is constipation? is defined as having a bowel movement less than 3 times per week. It is usually associated with hard stools or difficulty passing stools. You may have pain while passing stools or
More informationPaediatric constipation and functional non-retentive faecal soiling Voskuijl, W.P.
UvA-DARE (Digital Academic Repository) Paediatric constipation and functional non-retentive faecal soiling Voskuijl, W.P. Link to publication Citation for published version (APA): Voskuijl, W. P. (2005).
More informationA guide to Anoplasty (anal surgery)
Saint Mary s Hospital Newborn Intensive Care Unit Information for Parents A guide to Anoplasty (anal surgery) Introduction This information leaflet is designed to help parents and families to care for
More informationChapter 22. Bowel Needs. Copyright 2019 by Elsevier, Inc. All rights reserved.
Chapter 22 Bowel Needs Copyright 2019 by Elsevier, Inc. All rights reserved. Lesson 22.1 Define the key terms and key abbreviations in this chapter. Describe normal defecation and the observations to report.
More informationAging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS OVERVIEW
Aging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS A major medical conditions that commonly is seen among persons with IDD and may lead to serious complications is constipation.
More informationMOVICOL Junior Powder for Solution (macrogol 3350)
MOVICOL Junior Powder for Solution (macrogol 3350) Product Name: MOVICOL Junior Product Description: Each sachet of MOVICOL Junior contains: Macrogol 3350 Sodium chloride Sodium bicarbonate Potassium chloride
More informationFecal Incontinence. What is fecal incontinence?
Scan for mobile link. Fecal Incontinence Fecal incontinence is the inability to control the passage of waste material from the body. It may be associated with constipation or diarrhea and typically occurs
More informationManaging Defecation Disorders in Children
A SUPPLEMENT TO Internal Medicine News Managing Defecation Disorders in Children Perspectives on Constipation and Encopresis: Current Issues and New Findings Infant Dyschezia and Functional Constipation
More informationConstipation. H. David Vargas, MD. Overview
Constipation H. David Vargas, MD Overview Constipation is a very common complaint affecting upwards of 15% of all Americans. Fortunately, constipation usually is simple to avoid and easy to treat when
More informationChapter 31 Bowel Elimination
Chapter 31 Bowel Elimination Defecation Defecation: the act of expelling feces from the body Peristalsis: rhythmic contractions of intestinal smooth muscle to facilitate defecation Gastrocolic reflex:
More informationBowel and Bladder Dysfunction (BBD) Naida Kalloo, MD Pediatric Urology Children s National
Bowel and Bladder Dysfunction (BBD) Naida Kalloo, MD Pediatric Urology Children s National What is Bowel and Bladder Dysfunction? Lower urinary tract symptoms (LUTS) and bowel movement disorders Majority
More informationConstipation. Disease Review
bowel. 1 Constipation is a symptom, not a disease. Almost everyone experiences Disease Review Constipation Introduction: Constipation is exceedingly common and is rarely associated with mortality in developed
More informationConstipation in children usually is functional (ie, constipation
Efficacy and Complications of Polyethylene Glycols for Treatment of Constipation in Children A Meta-Analysis Si-Le Chen, MD, Shi-Rong Cai, MD, PhD, Liang Deng, MD, Xin-Hua Zhang, MD, PhD, Te-Dong Luo,
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients:
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Macrovic Junior powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution
More informationIrritable Bowel Syndrome Now. George M. Logan, MD Friday, May 5, :35 4:05 PM
Irritable Bowel Syndrome Now George M. Logan, MD Friday, May 5, 2017 3:35 4:05 PM Dr. Logan indicated no potential conflict of interest to this presentation. He does not intend to discuss any unapproved/investigative
More informationApproaching Childhood Constipation Anees Siddiqui, MD Pediatric Gastroenterology. Disclosure. Learning Objectives. Epidemiology.
Approaching Childhood Constipation p Anees Siddiqui, MD Pediatric Gastroenterology Disclosure Anees Siddiqui, MD, has no relationships with commercial companies to disclose. Specially for Children Dell
More informationPresenter. Irritable Bowel Syndrome. Objectives. Introduction. Rome Criteria. Irritable Bowel Syndrome 2/28/2018
Presenter Irritable Bowel Syndrome Current evidence for diagnosis & management Julie Daniels DNP, CNM Assistant Professor Course Coordinator of Primary Care of Women Faculty at Frontier Nursing University
More informationFormulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.
Formulations and Availability S TU D I E S PE R D I S E A S E 39 LIVER Liver Disease, Cirrhosis, Liver Failure, Hepatic Encephalopathy S TU D I E S PE R AG E G RO U P Visbiome Regular Product Code: 693-0412-01
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lacrofarm Junior, powder for oral solution, sachet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of contains the following active
More informationRobotic Ventral Rectopexy
Robotic Ventral Rectopexy What is a robotic ventral rectopexy? The term rectopexy refers to an operation in which the rectum (the part of the bowel nearest the anus) is put back into its normal position
More informationFaecal Incontinence Information Leaflet THE DIGESTIVE SYSTEM
THE DIGESTIVE SYSTEM This factsheet is about faecal incontinence Faecal (or anal) incontinence is the loss of stool, liquid or gas from the bowel at an undesirable time. Males and females of any age may
More informationDiagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider
Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider Elizabeth Coss, MD General Gastroenterologist Audie Murphy Veterans Hospital UT Health This presentation does not
More informationFunctional constipation in children: which treatment is effective and safe? An evidence-based case report
Functional constipation in children: which treatment is effective and safe? An evidence-based case report 1. Private practice, Quebec, Canada. Email: nathaelle@chirostmartin.com By Nathaëlle Martin-Marcotte,
More informationPolyethylene Glycol versus Paraffin for the Treatment of Childhood Functional Constipation
Original Article Iran J Pediatr Sep 2009; Vol 19 (No 3), Pp:255-261 Polyethylene Glycol versus Paraffin for the Treatment of Childhood Functional Constipation Hasan Karami* 1, MD; Mohammad Khademloo 2,
More informationChronic constipation, often accompanied by encopresis. Childhood Constipation: Longitudinal Follow-up Beyond Puberty. Patients and Methods
GASTROENTEROLOGY 2003;125:357 363 Childhood Constipation: Longitudinal Follow-up Beyond Puberty RIJK VAN GINKEL,* JOHANNES B. REITSMA, HANS A. BÜLLER, MICHIEL P. VAN WIJK,* JAN A. J. M. TAMINIAU,* and
More informationClinical problems related to GI involvement in SSc
Clinical problems related to GI involvement in SSc Incontinence Abdominal pain/distension Gastro-oesophageal Diarrhoea Weight loss/al Issues Constipation Management of incontinence Establish diagnosis
More informationClinical guideline Published: 26 May 2010 nice.org.uk/guidance/cg99
Constipation in children and young people: diagnosis and management Clinical guideline Published: 26 May 2010 nice.org.uk/guidance/cg99 NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Premeeting briefing Prucalopride for the treatment of chronic constipation in women
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Premeeting briefing Prucalopride for the treatment of chronic constipation in women This briefing presents the key issues arising from the manufacturer
More informationMOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350)
MOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350) Product Name: MOVICOL Junior Chocolate Flavour Product Description: Each sachet of MOVICOL Junior Chocolate contains: Macrogol 3350
More informationThe long-term impact of the low-fodmap diet for management of irritable bowel syndrome. Dr Miranda Lomer RD.
The long-term impact of the low-fodmap diet for management of irritable bowel syndrome Dr Miranda Lomer RD Email: miranda.lomer@kcl.ac.uk What is IBS - ROME IV Criteria A functional bowel disorder in which
More informationCOMMON PROBLEMS IN PAEDIATRIC GASTROENTEROLOGY AKSHAY BATRA CONSULTANT PAEDIATRIC GASTROENTEROLOGIST
COMMON PROBLEMS IN PAEDIATRIC GASTROENTEROLOGY AKSHAY BATRA CONSULTANT PAEDIATRIC GASTROENTEROLOGIST Paediatric Gastroenterology : Referral Base Common problems Feeding difficulties in infancy Recurrent
More informationWomen s and Men s Health Intake Form Comprehensive Physical Therapy Center
Name: (Last, First) DOB: Date: Age: Referring Physician: Next Physician Appointment: Today s visit: What is the main reason you came to the office today? When did it start? What treatments have you had
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme Surveillance review consultation document 4-year surveillance review of CG99: Diagnosis and management
More informationMANAGING CONSTIPATION
MANAGING CONSTIPATION INFORMATION FOR OLDER ADULTS, FAMILIES, AND CAREGIVERS READ THIS PAMPHLET TO LEARN: What Constipation is. The Symptoms of Constipation. How to Help Manage Constipation. WHAT IS CONSTIPATION?
More informationBowel Function After Spinal Cord Injury
Bowel Function After Spinal Cord Injury A resource for individuals with SCI and their supporters This presentation is based on SCI Model Systems research and was developed with support from the National
More informationCurrent Pharmacological Treatment Options in Chronic Constipation and IBS with Constipation
Current Pharmacological Treatment Options in Chronic Constipation and IBS with Constipation Anthony Lembo, M.D. Associate Professor of Medicine Harvard Medical School Director, GI Motility Center Beth
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Constipation: the diagnosis and management of idiopathic childhood constipation in primary and secondary care 1.1 Short title
More informationOPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES
OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES Introduction Introduction Mean faecal weight 128 g / cap / day Mean range 51-796 g Absolute range 15-1505 g Main factors affecting mass are caloric intake,
More informationUNDERSTANDING IBS AND CC Implications for diagnosis and management
UNDERSTANDING IBS AND CC Implications for diagnosis and management J. TACK, M.D., Ph.D. Department of Gastroenterology University Hospitals, K.U. Leuven Leuven, Belgium TYPES OF GASTROINTESTINAL DISORDERS
More informationTRANSPARENCY COMMITTEE OPINION. 10 December 2008
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 10 December 2008 RELISTOR 12 mg/0.6 ml solution for injection 1 vial (CIP: 387 365-1) 2 vials + 2 sterile syringes
More informationfrom Bowel Control Problems twitter.com/voicesforpfd
BREAK FREE from Bowel Control Problems POP Quiz THE NUMBER OF PEOPLE IN THE UNITED STATES WITH BOWEL CONTROL PROBLEMS: A. 6 million B. 12 million C. 18 million BOWEL CONTROL PROBLEMS Nearly 18 million
More informationNursing Principles & Skills II. Bowel Sounds Constipation Fecal Impaction
Nursing Principles & Skills II Bowel Sounds Constipation Fecal Impaction Bowel Sounds Definitionthe noise or sounds made by the peristaltic waves of the intestinal muscle contracting and relaxing Bowel
More informationEtiology and Clinical Spectrum of Constipation in Indian Children
R E S E A R C H P A P E R Etiology and Clinical Spectrum of Constipation in Indian Children VIKRANT KHANNA*, UJJAL PODDAR AND SURENDER KUMAR YACHHA From the Departments of Pediatric Gastroenterology and
More informationSlide #43. Functional Disorders - An Update 11/8/ MA ACP Annual Scientific Meeting. Functional Disorders: An Update
Functional Disorders: An Update Anthony Lembo, M.D. Associate Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA Disclosure of Financial Relationships Anthony
More informationThere are clues to help to decide if the bellyache is a medical problem:
Bellyaches in Children Pediatric and Adolescent Gastrointestinal Motility & Pain Program Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana By: Paul Hyman,
More informationIBS: overview and assessment of pain outcomes and implications for inclusion criteria
IBS: overview and assessment of pain outcomes and implications for inclusion criteria William D. Chey, MD Professor of Medicine University of Michigan What is the Irritable Bowel Syndrome Symptom based
More informationOutlet syndrome: is there a surgical option?'
Journal of the Royal Society of Medicine Volume 77 July 1984 559 Outlet syndrome: is there a surgical option?' M R B Keighley MS FRCS P Shouler FRCS Department of Surgery, General Hospital, Birmingham
More informationIrritable Bowel Disease. Dr. Alexandra Ilnyckyj MD
Irritable Bowel Disease Dr. Alexandra Ilnyckyj MD Exactly what is IBS? Common condition affecting mostly women Symptoms are variable but they reflect altered gut movement (motility) and sensation Commonly
More informationDrugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives
Drugs Affecting the Gastrointestinal System Antidiarrheal and Laxatives Diarrhea Abnormal frequent passage of loose stools or Abnormal passage of stools with increased frequency, fluidity, and weight,
More informationXifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary
Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2 Lotronex (alosetron) a Indication For women with severe diarrheapredominant irritable
More informationClinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut
Clinically proven to quickly relieve symptoms of common gastrointestinal disorders GASTROINTESTINAL DISEASE Referred to as gastrointestinal diseases, they are common disorders which affect the esophagus,
More information